For example, inhibition of both A2AR (adenosine 2A receptor) and the corticotrophin-releasing hormone receptor 1 (CRHR1) by inhibitors may improve cognitive function and reduce depression in AD patients. Here, ADORA2A is linked to Alzheimer disease.